{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T17:54:30Z","timestamp":1781718870848,"version":"3.54.5"},"reference-count":25,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T00:00:00Z","timestamp":1569542400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>Malignant pleural mesothelioma (MPM) is an aggressive cancer with poor prognosis. The main treatment for MPM is doublet chemotherapy with Cisplatin and Pemetrexed, while ongoing trials test the efficacy of pemetrexed monotherapy. However, there is lack of evidence regarding the effects of Cisplatin and Pemetrexed on MPM cell phenotypes, especially in three-dimensional (3D) cell cultures. In this study, we evaluated the effects Cisplatin and Pemetrexed on cell viability using homologous cell derived extracellular matrix (hECM) as substratum and subsequently in the following 3D cell culture phenotypes: tumor spheroid formation, tumor spheroid invasion, and collagen gel contraction. We used benign mesothelial MeT-5A cells as controls and the MPM cell lines M14K (epithelioid), MSTO (biphasic), and ZL34 (sarcomatoid). Cell viability of all cell lines was significantly decreased with all treatments. Mean tumor spheroid perimeter was reduced after treatment with Pemetrexed or the doublet therapy in all cell lines, while Cisplatin reduced the mean spheroid perimeter of MeT-5A and MSTO cells. Doublet treatment reduced the invasive capacity of spheroids of cell lines into collagenous matrices, while Cisplatin lowered the invasion of the MSTO and ZL34 cell lines, and Pemetrexed lowered the invasion of MeT-5A and ZL34 cell lines. Treatment with Pemetrexed or the combination significantly reduced the collagen gel contraction of all cell lines, while Cisplatin treatment affected only the MeT-5A and M14K cells. The results of the current study can be used as an in vitro 3D platform for testing novel drugs against MPM for ameliorating the effects of first line chemotherapeutics.<\/jats:p>","DOI":"10.3390\/cancers11101446","type":"journal-article","created":{"date-parts":[[2019,9,27]],"date-time":"2019-09-27T11:14:35Z","timestamp":1569582875000},"page":"1446","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["In Vitro Characterization of Cisplatin and Pemetrexed Effects in Malignant Pleural Mesothelioma 3D Culture Phenotypes"],"prefix":"10.3390","volume":"11","author":[{"given":"Eleftherios D.","family":"Papazoglou","sequence":"first","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Thessaly, Biopolis, 41500 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajesh M.","family":"Jagirdar","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Thessaly, Biopolis, 41500 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olympia A.","family":"Kouliou","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Thessaly, Biopolis, 41500 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanna","family":"Pitaraki","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Thessaly, Biopolis, 41500 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chrissi","family":"Hatzoglou","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Thessaly, Biopolis, 41500 Larissa, Greece"},{"name":"Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Biopolis, 41500 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos I.","family":"Gourgoulianis","sequence":"additional","affiliation":[{"name":"Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Biopolis, 41500 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3083-3244","authenticated-orcid":false,"given":"Sotirios G.","family":"Zarogiannis","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Medicine, University of Thessaly, Biopolis, 41500 Larissa, Greece"},{"name":"Department of Respiratory Medicine, Faculty of Medicine, University of Thessaly, Biopolis, 41500 Larissa, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2019,9,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3389\/fonc.2018.00091","article-title":"New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma","volume":"8","author":"Rossini","year":"2018","journal-title":"Front. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/S1470-2045(13)70257-2","article-title":"Asbestos is not just asbestos: an unrecognised health hazard","volume":"14","author":"Baumann","year":"2013","journal-title":"Lancet Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1080\/21678707.2017.1325358","article-title":"Current and prospective pharmacotherapies for the treatment of pleural mesothelioma","volume":"5","author":"Bakker","year":"2017","journal-title":"Expert Opin. Orphan Drugs"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/annonc\/mdv199","article-title":"Malignant pleural mesothelioma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"26","author":"Baas","year":"2015","journal-title":"Ann. Oncol."},{"key":"ref_5","first-page":"508","article-title":"Chemotherapy for malignant pleural mesothelioma: a review of current management and a look to the future","volume":"1","author":"Nowak","year":"2012","journal-title":"Ann. Cardiothorac. Surg."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2636","DOI":"10.1200\/JCO.2003.11.136","article-title":"Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural Mesothelioma","volume":"21","author":"Vogelzang","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: Molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.3816\/CLC.2004.s.003","article-title":"Pharmacology and mechanism of action of pemetrexed","volume":"5","author":"Adjei","year":"2004","journal-title":"Clin. Lung Cancer"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4997\/JRCPE.2015.207","article-title":"Survival from malignant mesothelioma: where are we now?","volume":"45","author":"Marshall","year":"2015","journal-title":"J. R. Coll. Physicians Edinb."},{"key":"ref_10","first-page":"964","article-title":"Pleural mesothelial cells in pleural and lung diseases","volume":"7","author":"Batra","year":"2015","journal-title":"J. Thorac. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.15252\/embr.201439246","article-title":"The extracellular matrix modulates the hallmarks of cancer","volume":"15","author":"Pickup","year":"2014","journal-title":"EMBO Rep."},{"key":"ref_12","doi-asserted-by":"crossref","unstructured":"Senthebane, D.A., Rowe, A., Thomford, N.E., Shipanga, H., Munro, D., Mazeedi, M.A.M., Al Almazyadi, H.A.M., Kallmeyer, K., Dandara, C., and Pepper, M.S. (2017). The Role of Tumor Microenvironment in Chemoresistance: To Survive, Keep Your Enemies Closer. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18071586"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Kim, H., Phung, Y., and Ho, M. (2012). Changes in Global Gene Expression Associated with 3D Structure of Tumors: An Ex Vivo Matrix-Free Mesothelioma Spheroid Model. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0039556"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"L489","DOI":"10.1152\/ajplung.00410.2015","article-title":"Influence of AQP1 on cell adhesion, migration, and tumor sphere formation in malignant pleural mesothelioma is substratum- and histological-type dependent","volume":"310","author":"Jagirdar","year":"2016","journal-title":"Am. J. Physiol. Cell Mol. Physiol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12931-017-0564-3","article-title":"Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts","volume":"18","author":"Lam","year":"2017","journal-title":"Respir. Res."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1177\/0960327114542965","article-title":"EF24 and RAD001 potentiates the anticancer effect of platinum-based agents in human malignant pleural mesothelioma (MSTO-211H) cells and protects nonmalignant mesothelial (MET-5A) cells","volume":"34","author":"Onen","year":"2015","journal-title":"Hum. Exp. Toxicol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1016\/j.bbamcr.2016.08.009","article-title":"Decellularized matrices as in vitro models of extracellular matrix in tumor tissues at different malignant levels: Mechanism of 5-fluorouracil resistance in colorectal tumor cells","volume":"1863","author":"Hoshiba","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Cortes-Dericks, L., Froment, L., Boesch, R., Schmid, R.A., and Karoubi, G. (2014). Cisplatin-resistant cells in malignant pleural mesothelioma cell lines show ALDHhighCD44+ phenotype and sphere-forming capacity. BMC Cancer, 14.","DOI":"10.1186\/1471-2407-14-304"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"3809","DOI":"10.21873\/anticanres.13530","article-title":"2-deoxy-glucose enhances the effect of cisplatin and pemetrexed in reducing malignant pleural mesothelioma cell proliferation but not spheroid growth","volume":"39","author":"Gerogianni","year":"2019","journal-title":"Anticancer Res."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1007\/s00109-018-1725-7","article-title":"The FAK inhibitor BI 853520 inhibits spheroid formation and orthotopic tumor growth in malignant pleural mesothelioma","volume":"97","author":"Laszlo","year":"2019","journal-title":"J. Mol. Med. (Berl.)"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/s41598-018-21200-8","article-title":"In vitro patient-derived 3D mesothelioma tumor organoids facilitate patient-centric therapeutic screening","volume":"8","author":"Mazzocchi","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_22","first-page":"355","article-title":"In vitro-chemosensitivity test using the collagen gel droplet embedded culture drug test (CD-DST) for malignant pleural mesothelioma: Possibility of clinical application","volume":"14","author":"Higashiyama","year":"2008","journal-title":"Ann. Thorac. Cardiovasc. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"10070","DOI":"10.1038\/s41598-018-28297-x","article-title":"Pirfenidone decreases mesothelioma cell proliferation and migration via inhibition of ERK and AKT and regulates mesothelioma tumor microenvironment in vivo","volume":"8","author":"Li","year":"2018","journal-title":"Sci. Rep."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/php.13067","article-title":"Modeling Epidermal Growth Factor Inhibitormediated Enhancement of Photodynamic Therapy Efficacy Using 3D Mesothelioma Cell Culture","volume":"95","author":"Cramer","year":"2019","journal-title":"Photochem. Photobiol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Lachaud, C.C., Pezzolla, D., Dom\u00ednguez-Rodr\u00edguez, A., Smani, T., Soria, B., and Hmadcha, A. (2013). Functional Vascular Smooth Muscle-like Cells Derived from Adult Mouse Uterine Mesothelial Cells. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0055181"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/10\/1446\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:24:54Z","timestamp":1760189094000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/11\/10\/1446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9,27]]},"references-count":25,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2019,10]]}},"alternative-id":["cancers11101446"],"URL":"https:\/\/doi.org\/10.3390\/cancers11101446","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,9,27]]}}}